{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:40:58Z","timestamp":1782513658872,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.contraception.2016.07.013","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T00:19:36Z","timestamp":1469146776000},"page":"612-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Contraceptive use among women with multiple sclerosis: a systematic review"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6536-7124","authenticated-orcid":false,"given":"Lauren B.","family":"Zapata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilope","family":"Oduyebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Houtchens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly A.","family":"Marchbanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.07.013_bb0005","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1586\/14737175.7.9.1213","article-title":"Multiple sclerosis symptom management","volume":"7","author":"Boissy","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.contraception.2016.07.013_bb0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2016.07.013_bb0015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new agents in multiple sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2016.07.013_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp-2014-307791","article-title":"Modelling the natural history of primary progressive multiple sclerosis","volume":"86","author":"Harding","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.contraception.2016.07.013_bb0025","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/00207454.2013.840618","article-title":"Epidemiology and clinical record of multiple sclerosis in selected countries: a systematic review","volume":"124","author":"Niedziela","year":"2014","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.contraception.2016.07.013_bb0030","series-title":"U.S. and world population clock","author":"United States Census Bureau","year":"2015"},{"key":"10.1016\/j.contraception.2016.07.013_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048078","article-title":"Geographical variations in sex ratio trends over time in multiple sclerosis","volume":"7","author":"Trojano","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2016.07.013_bb0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1352458513519181","article-title":"The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis","volume":"20","author":"Bove","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.contraception.2016.07.013_bb0045","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/AOG.0000000000000541","article-title":"Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review","volume":"124","author":"Bove","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0050","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00415-012-6653-9","article-title":"Multiple sclerosis and pregnancy: therapeutic considerations","volume":"260","author":"Houtchens","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2009.04.038","article-title":"Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence","volume":"286","author":"Alonso","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.contraception.2016.07.013_bb0060","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jth.12523","article-title":"The risk of venous thromboembolism in patients with multiple sclerosis: the clinical practice research Datalink","volume":"12","author":"Peeters","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2016.07.013_bb0065","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/ene.12518","article-title":"Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study","volume":"21","author":"Roshanisefat","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/practneurol-2012-000435","article-title":"Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes","volume":"13","author":"Dobson","year":"2013","journal-title":"Pract Neurol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/1352458512452331","article-title":"Female reproductive issues in multiple sclerosis","volume":"19","author":"McCombe","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.contraception.2016.07.013_bb0080","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.10301","article-title":"Treatment of multiple sclerosis with the pregnancy hormone estriol","volume":"52","author":"Sicotte","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0085","first-page":"1","article-title":"U. S. Medical eligibility criteria for contraceptive use, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2016.07.013_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2016.07.013_bb0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US preventive services task force: a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2016.07.013_bb0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.fertnstert.2014.03.054","article-title":"Long-term influence of combined oral contraceptive use on the clinical course of relapsing\u2013remitting multiple sclerosis","volume":"102","author":"Gava","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2016.07.013_bb0105","first-page":"323","article-title":"Contraception and multiple sclerosis","volume":"53","author":"Poser","year":"1982","journal-title":"Nervenarzt"},{"key":"10.1016\/j.contraception.2016.07.013_bb0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000120","article-title":"Oral contraceptives combined with interferon beta in multiple sclerosis","volume":"2","author":"Pozzilli","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.contraception.2016.07.013_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2012.02.033","article-title":"Oral contraceptive use and clinical outcomes in patients with multiple sclerosis","volume":"317","author":"Sena","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.contraception.2016.07.013_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0404.1979.tb02917.x","article-title":"Pregnancy, oral contraceptives and multiple sclerosis","volume":"59","author":"Poser","year":"1979","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.contraception.2016.07.013_bb0125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00415-011-6267-7","article-title":"Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis","volume":"259","author":"D'Hooghe","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.maturitas.2005.10.003","article-title":"Symptoms of multiple sclerosis in women in relation to sex steroid exposure","volume":"54","author":"Holmqvist","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2016.07.013_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0022-510X(79)90201-6","article-title":"Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system","volume":"40","author":"Poser","year":"1979","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.contraception.2016.07.013_bb0140","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2016.07.013_bb0145","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2016.07.013_bb0150","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/WNL.11.8.686","article-title":"On the evaluation of disability in multiple sclerosis","volume":"11","author":"Kurtzke","year":"1961","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2016.07.013_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1468-1331.2003.00513.x","article-title":"Cerebral venous thrombosis in four patients with multiple sclerosis","volume":"10","author":"Vandenberghe","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0160","first-page":"155","article-title":"[cerebral venous thrombosis after lumbar puncture and intravenous steroids in two patients with multiple sclerosis]","volume":"156","author":"Stadler","year":"2000","journal-title":"Rev Neurol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00002060-199407000-00011","article-title":"Intracranial venous thrombosis in a patient with multiple sclerosis. A case report and review of contraceptive alternatives in patients with disabilities","volume":"73","author":"Malanga","year":"1994","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.contraception.2016.07.013_bb0170","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/13625180903137329","article-title":"Symptoms of multiple sclerosis in women in relation to cyclical hormone changes","volume":"14","author":"Holmqvist","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2016.07.013_bb0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(97)05396-3","article-title":"Menstrually related worsening of symptoms in multiple sclerosis","volume":"149","author":"Zorgdrager","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.contraception.2016.07.013_bb0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000066166","article-title":"The premenstrual period and exacerbations in multiple sclerosis","volume":"48","author":"Zorgdrager","year":"2002","journal-title":"Eur Neurol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0185","first-page":"209","article-title":"The management of multiple sclerosis. 3. Apparent suppression of symptoms by an estrogen-progestin compound","volume":"66","author":"McFarland","year":"1969","journal-title":"Mo Med"},{"key":"10.1016\/j.contraception.2016.07.013_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2015.06.030","article-title":"Symptoms of multiple sclerosis during use of combined hormonal contraception","volume":"193","author":"Kempe","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0195","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/1352458511398885","article-title":"Critical appraisal of animal models of multiple sclerosis","volume":"17","author":"Baker","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.contraception.2016.07.013_bb0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yfrne.2011.12.001","article-title":"Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration","volume":"33","author":"Spence","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.maturitas.2010.09.014","article-title":"Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids","volume":"68","author":"El-Etr","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2016.07.013_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","article-title":"Epidemiology and risk factors for venous thrombosis","volume":"44","author":"Cushman","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1016\/j.contraception.2016.07.013_bb0215","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.07.013_bb0220","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1177\/1352458512453362","article-title":"Bone health and multiple sclerosis","volume":"18","author":"Dobson","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.contraception.2016.07.013_bb0225","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jbmr.418","article-title":"The risk of fracture in patients with multiple sclerosis: the UK general practice research database","volume":"26","author":"Bazelier","year":"2011","journal-title":"J Bone Miner Res"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T05:26:33Z","timestamp":1536557193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416301676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0010782416301676"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.07.013","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraceptive use among women with multiple sclerosis: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}